Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,629,801
+$818,942 QoQ
Shares Held
144,979
-2.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#541
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. MRK ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,629,801 | 144,979 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,810,859 | 148,066 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,069,938 | 152,669 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,608,074 | 162,136 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,006,943 | 202,210 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,298,480 | 270,705 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $83,219,496 | 836,545 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $92,683,470 | 816,163 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $99,615,422 | 804,648 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $107,107,641 | 811,729 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $89,815,472 | 823,844 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $87,629,907 | 851,189 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $99,362,675 | 861,103 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $92,667,711 | 871,019 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $116,831,015 | 1,053,006 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $102,767,771 | 1,193,309 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $108,729,980 | 1,192,607 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $97,618,413 | 1,189,743 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $100,794,858 | 1,315,173 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $100,644,771 | 1,339,965 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $101,787,631 | 1,308,829 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $80,381,478 | 1,042,696 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $80,407,155 | 982,973 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $80,715,696 | 973,064 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $74,522,489 | 963,694 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $73,624,547 | 956,909 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||